Table 1.
Identifier |
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P1 | P2 | P3 | P4 | P5 | P6 | P7 | P8 | P9 | P10 | P11 | P12 | P13 | P14 | P15 | P16 | P17 | ||
Age at evaluation, years | 11 | 0.3 | 22 | 24 | 0.9 | 5 | 10 | 13 | 13 | 16 | 0.1 | 0.6 | 10 | 12 | 13 | 6 | 0.3 | |
Clinical diagnosis | RMS | DS | RMS | RMS | DS | DS | RMS | RMS | RMS | RMS | DS | DS | DS | RMS | RMS | RMS | DS | |
INSR mutation(s) | P.L109R/g.26624_26625delA | P-N431D (H) | P-P193L (H) | P-P193L (H) | P-C274Y/P-R1174W | P-R114W (H) | P-R899Q/IVS18-1G>T | P-L460E/P-L109R | P.I119M (H) | P-S608L/del ex9-10 | P-Q521X (H) | P-G84Q (H) | P.I119M/P-R1039X | P-Y30X/P-E238L | R1092Q (H) | P-V66A/del ex18 | IVS7 + ldelT/p.325_331 del | |
Weight, kg | 25.2 | 2.0 | 30.9 | 35.0 | 3.7 | – | 24.4 | 36.2 | 37.9 | 38.2 | 1.44 | 3.0 | 19.0 | 35.8 | 12.4 | 12.5 | 2.8 | |
Plasma creatinine, | μmol/l | 13.9 | 30 | 12.8 | 19.4 | 20 | 20 | 48 | 20 | 19 | 13.3 | 20.5 | 12 | 22 | 22 | 23 | 8 | – |
Plasma total | calcium, mmol/1 | 2.34 | 2.78 | 2.3* | 2.23* | 2.51* | 2.36 | 2.72 | 2.09 | 2.21 | 2.28 | 2.65 | 2.27 | 2.43 | 2.26 | 2.43* | 2.26 | – |
Plasma potassium, mmol/1 | 3.6 | 4.8 | 4.0 | 4.2 | 3.2 | 3.8 | 3.9 | 3.0 | – | 3.9 | 3.8 | 2.8 | 3.6 | 3.8 | 4.2 | 3.5 | – | |
Plasma chloride, mmol/1 | 103 | 96 | 103 | 104 | 93 | – | 102 | 102 | 102 | 104 | 101 | 98 | 104 | 103 | 92 | – | – | |
Plasma tCO2, mmol/1 | 26 | 28 | 26 | 27 | 28 | – | – | 23 | – | 25 | – | 29 | 27 | 27 | 29 | 19 | – | |
Plasma magnesium, mmol/1 | 0.71 | 1.0 | 0.75 | 0.78 | 0.67 | – | 0.8 | 0.65 | – | 0.59 | 0.5 | 0.95 | 0.67 | – | 0.95 | 0.64 | – | |
Urinary calcium excretion1, mmol/kg/24 h | 0.14 | 0.45 | 0.12 | 0.41 | 0.18 | 0.29 | 0.35 | 0.68 | 0.21 | 0.38 | ||||||||
Presence of nephrocalcinosis | yes | yes | yes | yes | yes | yes | yes | yes | yes | yes | yes | yes | yes | yes | yes | yes | yes |
Not all data were available for all patients. Plasma calcium values are not corrected for plasma albumin, unless indicated by*, as albumin levels were not available in all. Note that nephrocalcinosis was noted in all patients. Mutation annotation is according to the mature isoform B of the INSR, based on reference sequence P062134.4. Note that amino acids are numbered from the first codon of the mature receptor, which means that they are 27 less than the numbering of the reference sequence.
(H) = Homozygous.